Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
depot formulation
Description:
A long-acting drug formulation designed to release medication gradually after administration, often by injection or implantation.
Related topics:
Schizophrenia research and treatment (18%),
Prostate Cancer Treatment and Research (17%),
Advanced Drug Delivery Systems (12%)
OpenAlex ID:
keywords/depot-formulation
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate
1997
·
Hiroaki Okada
·
Advanced Drug Delivery Reviews
·
408
Somatostatin Analogs in Acromegaly
2002
·
P. U. Freda
·
The Journal of Clinical Endocrinology & Metabolism
·
310
Injectable Corticosteroids in Modern Practice
2005
·
Brian J. Cole
, Ralph H. Schumacher
·
Journal of the American Academy of Orthopaedic Surgeons
·
246
Clinical Pharmacokinetics of Depot Leuprorelin
2002
·
Piero Periti
, Teresita Mazzei
, et al.
·
Clinical Pharmacokinetics
·
190
An ein kolloidales Blutplasma-Ersatzmittel (Polyvinylpyrrolidon) gebundenes Peptamin (Glycyl-L-leucyl-mezcalin) als neuartige Depotform für biologisch aktive primäre Amine (Mezcalin)
1955
·
Horst Jatzkewitz
·
Zeitschrift für Naturforschung B
·
178
PDF
Supramolecular cyclodextrin-based drug nanocarriers
2015
·
Susana M. N. Simões
, Ana Rey-Rico
, et al.
·
Chemical Communications
·
177
Mechanisms of Antineoplastic Action of Somatostatin Analogs
1998
·
M. N. Pollak
, A. V. Schally
·
Experimental Biology and Medicine
·
172
The Medicinal Chemistry of Peptides
2009
·
J. Nestor Jr.
·
Current Medicinal Chemistry
·
153
Applications of GnRH in the control and management of fertility in female animals
2005
·
C.A. Herbert
, T.E. Trigg
·
Animal Reproduction Science
·
153
Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics.
2003
·
Larry Ereshefsky
, Cynthia A Mascarenas
·
PubMed
·
143
Pharmacokinetics and Pharmacodynamics of GnRH Agonists: Clinical Implications in Pediatrics
2000
·
N. Lahlou
, J.-C. Carel
, et al.
·
Journal of Pediatric Endocrinology and Metabolism
·
143
Formulation and Delivery of Proteins and Peptides
1994
·
Jeffrey L. Cleland1
, Robert Langer2
·
ACS symposium series
·
141
Formulation and Delivery of Proteins and Peptides: Design and Development Strategies
1994
·
Jeffrey L. Cleland
, Robert Langer
·
ACS symposium series
·
140
Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
2013
·
Eun Ji Park
, Sarmila Amatya
, et al.
·
Archives of Pharmacal Research
·
135
A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations
1999
·
Mohammed Shameem
, Heeyong Lee
, et al.
·
AAPS PharmSci
·
134
PDF
Patient Compliance with Drug Therapy in Schizophrenia: Economic and Clinical Issues
2000
·
Eva Lindström
, Kerstin Bingefors
·
PharmacoEconomics
·
126
Clinical Study of Leuprolide Depot Formulation in the Treatment of Advanced Prostate Cancer
1990
·
Roohollah Sharifi
, Mark Soloway
·
The Journal of Urology
·
122
Upcoming Agents for the Treatment of Schizophrenia: Mechanism of Action, Efficacy and Tolerability
2008
·
Delia Bishara
, David Taylor
·
Drugs
·
113
Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report
1993
·
Jeffrey R. Nelson
, Stephen L. Corson
·
Fertility and Sterility
·
112
Hormone Therapy in Prostate Cancer: LHRH Antagonists versus LHRH Analogues
2004
·
Dorothea Weckermann
, Rolf Harzmann
·
European Urology
·
111
Biophysical properties of phospholipids. I. Interaction of phosphatidylserine monolayers with metal ions
1966
·
Alec D. Bangham
, Demetrios Papahadjopoulos
·
Biochimica et Biophysica Acta (BBA) - Biophysics including Photosynthesis
·
109
The role of polymer membrane formation in sustained release drug delivery systems
2005
·
A.J. McHugh
·
Journal of Controlled Release
·
108
Pharmacokinetic Features of the Antiparasitic Macrocyclic Lactones
2012
·
Quintin A. McKellar
, Cengiz Gokbulut
·
Current Pharmaceutical Biotechnology
·
102
Effects of Route and Formulation on Clinical Pharmacokinetics of Interleukin-2
1994
·
Peter M. Anderson
, Mark A. Sorenson
·
Clinical Pharmacokinetics
·
95
Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix
1998
·
R. E. Felberbaum
, U. Germer
, et al.
·
Human Reproduction
·
92
Show more works
View as search
Works count:
738
Citation count:
10,950
Year
Topic
Type